Showing results (951-960 of 1,011) with videos related to
Sort By:
Pageof 102
NPJ Vaccines|May 5, 2025
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigensMark D Langowski, Joseph R Francica, Alex L Roederer, et al.Protist|March 2, 2016
Defining Planktonic Protist Functional Groups on Mechanisms for Energy and Nutrient Acquisition: Incorporation of Diverse Mixotrophic StrategiesAditee Mitra, Kevin J Flynn, Urban Tillmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2019
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, et al.Cell Reports|June 30, 2023
Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protectionManuela C Aguirre-Botero, Lawrence T Wang, Pauline Formaglio, et al.Immunity|July 21, 2016
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone MiceAmanda Poissonnier, Doriane Sanséau, Matthieu Le Gallo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.The Journal of Urology|October 3, 2025
The Artificial Urinary Sphincter Clinical Outcomes Trial: Primary ResultsMelissa R Kaufman, Hadley M Wood, Ryan Terlecki, et al.Patient Preference and Adherence|August 23, 2013
Facilitators and barriers to hypertension self-management in urban African Americans: perspectives of patients and family membersSarah J Flynn, Jessica M Ameling, Felicia Hill-Briggs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancerEdward H Romond, Jong-Hyeon Jeong, Priya Rastogi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, et al.Pageof 102